MEDULLARY THYROID CARCINOMA
Clinical trials for MEDULLARY THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MEDULLARY THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for MEDULLARY THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could boost cure rates for rare thyroid cancer
⭐️ CURE ⭐️ Recruiting nowThis study tests whether a special PET scan (68Ga-CTR-FAPI) can help surgeons remove all medullary thyroid cancer during the first surgery, aiming for a cure. About 150 newly diagnosed patients will be split into two groups: one gets surgery guided by the new scan, the other gets…
Matched conditions: MEDULLARY THYROID CARCINOMA
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowThis early study tests a personalized mRNA vaccine (mRNA-0523-L001) for people with advanced endocrine tumors like adrenal cancer, medullary thyroid cancer, and pancreatic neuroendocrine tumors who have no standard treatment left. The vaccine is made to target unique mutations in…
Matched conditions: MEDULLARY THYROID CARCINOMA
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Researchers track rare thyroid cancer to uncover its secrets
Knowledge-focused Recruiting nowThis study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2. Researchers will track how the cancer grows and affects health over time using regular check-ups, blood tests, and imaging. No treatment is given, but part…
Matched conditions: MEDULLARY THYROID CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study aims to create clearer cancer education for hispanic patients
Knowledge-focused Recruiting nowThis study will adapt educational materials about medullary thyroid cancer to be more culturally appropriate and easier to understand for Spanish-speaking Hispanic or Latino patients. Researchers will interview 40 participants, including patients and caregivers, to gather feedbac…
Matched conditions: MEDULLARY THYROID CARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Massive registry study aims to unlock secrets of rare thyroid cancer
Knowledge-focused Recruiting nowThis study uses a large registry of 2030 people with medullary thyroid cancer to track how the disease develops and spreads. Researchers will collect medical records, genetic data, and patient surveys to better understand the cancer's natural history. The goal is to improve how a…
Matched conditions: MEDULLARY THYROID CARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New decision aid empowers thyroid cancer patients to choose their care path
Knowledge-focused Recruiting nowThis study creates and tests a decision aid for people with medullary thyroid cancer and their caregivers. The tool helps them discuss with their doctors whether to start or stop drugs, join clinical trials, or continue active monitoring. About 120 participants, including patient…
Matched conditions: MEDULLARY THYROID CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC